Flagship explainer
How IOVANCE BIOTHERAPEUTICS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $264M | 100% |
| |
| Cost of revenue | $173M | 66% |
|
| $90.3M | 34% |
| |
| −$403M | −153% |
| |
| Income before tax | −$393M | −149% |
|
| Income tax | −$2.1M | −1% |
|
| −$391M | −148% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001104659-26-018899